INSULET CORP·4

Nov 14, 4:04 PM ET

Petrovic Shacey 4

4 · INSULET CORP · Filed Nov 14, 2023

Insider Transaction Report

Form 4
Period: 2023-11-13
Transactions
  • Exercise/Conversion

    Common Stock

    2023-11-13$74.50/sh+11,838$881,93114,405 total
  • Exercise/Conversion

    Common Stock

    2023-11-13$92.11/sh+8,162$751,80222,567 total
  • Sale

    Common Stock

    2023-11-13$165.02/sh2,075$342,41741,130 total(indirect: By Trust)
  • Sale

    Common Stock

    2023-11-13$165.02/sh12,925$2,132,8840 total(indirect: By Trust)
  • Sale

    Common Stock

    2023-11-13$164.33/sh20,000$3,286,6002,567 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-11-1311,8380 total
    Exercise: $74.50Exp: 2028-02-14Common Stock (11,838 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-11-138,16211,609 total
    Exercise: $92.11Exp: 2029-02-26Common Stock (8,162 underlying)
Footnotes (3)
  • [F1]The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $164.02 to $164.85. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F2]This option, which is fully vested, vested over a four-year period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters.
  • [F3]This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT